Hemodynamic Changes During Dry Cupping Therapy on Low Back Pain
Primary Purpose
Oxygen Metabolism, Muscle Spasticity
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Negative pressure therapy
Sponsored by
About this trial
This is an interventional supportive care trial for Oxygen Metabolism focused on measuring Cupping Therapy, Near Infrared Spectroscopy
Eligibility Criteria
Inclusion Criteria:
- Patients who have had non-specific low back pains at least 12 weeks now.
- Healthy people who are interested in dry cupping therapy
Exclusion Criteria:
- Patients who have had non-specific low back pains at least 12 weeks now.
- Healthy people who are interested in dry cupping therapy
Exclusion Criteria:
- Patients who have low back pain due to specific and known etiological causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome, cauda equinal syndrome).
Patients who are inappropriate to the wet cupping treatment.
- AIDS, Active Hepatitis, Tuberculosis, Syphilis
- Patients who regularly take anticoagulants, antiplatelet drugs
- Anemia, thrombocytopenia
- Hemorrhagic disease like hemophilia
- Diabetes
- Severe cardiovascular disease
- Kidney diseases (renal failure, chronic renal disease)
- Patients who have experiences of wet cupping treatment during last 3 months.
- Patients who have had treatment for low back pain during last 2 weeks.
- Patients who are in pregnancy or have plan to conception.
- Patients who have vertebra surgery or have plan of surgery.
- Patients who are inappropriate to join this trial judged by the radiologists or specialists.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
dry cupping for patients of low back pain
dry cupping for health people
Arm Description
Patients will receive four consecutive dry cupping therapy application in one month.
Health people will receive four consecutive dry cupping therapy application in one month.
Outcomes
Primary Outcome Measures
Δ[HbO2]
the concentration changes of oxyhemoglobin (higher alternation means better curative effect)
Δ[Hb]
the concentration changes of deoxyhemoglobin (higher alternation means better curative effect)
Secondary Outcome Measures
Δ[tHb]
the concentration changes of blood volume (higher alternation means better curative effect)
NRS
Numeric Rating Scale for pain (lower score means better curative effect)
Full Information
NCT ID
NCT03816787
First Posted
January 20, 2019
Last Updated
July 22, 2019
Sponsor
Chinese Academy of Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT03816787
Brief Title
Hemodynamic Changes During Dry Cupping Therapy on Low Back Pain
Official Title
Hemodynamic Changes During Dry Cupping Therapy on Low Back Pain
Study Type
Interventional
2. Study Status
Record Verification Date
July 2019
Overall Recruitment Status
Unknown status
Study Start Date
December 1, 2019 (Anticipated)
Primary Completion Date
November 25, 2020 (Anticipated)
Study Completion Date
May 29, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chinese Academy of Medical Sciences
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study aims to investigate the hemodynamic changes during dry cupping therapy (DCT) on low back pain. 50 patients with low back pain as experimental group and 50 healthy people as control group are treated by DCT. They will receive four consecutive WCT application in one month. Optical sensors were used to monitor the hemodynamic changes including oxyhemoglobin ([HbO2]), deoxy-hemoglobin ([Hb]) and the derived change in blood volume ([tHb]) in/surround the cupping sites during treatment. The investigators hope to interpret the curative effect of DCT from the perspective of modern hemodynamics.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oxygen Metabolism, Muscle Spasticity
Keywords
Cupping Therapy, Near Infrared Spectroscopy
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
dry cupping for patients of low back pain
Arm Type
Experimental
Arm Description
Patients will receive four consecutive dry cupping therapy application in one month.
Arm Title
dry cupping for health people
Arm Type
Active Comparator
Arm Description
Health people will receive four consecutive dry cupping therapy application in one month.
Intervention Type
Procedure
Intervention Name(s)
Negative pressure therapy
Other Intervention Name(s)
Dry cupping therapy
Intervention Description
Participants assigned to the treatment group will receive wet-cupping therapy 1 times per week for 4 weeks
Primary Outcome Measure Information:
Title
Δ[HbO2]
Description
the concentration changes of oxyhemoglobin (higher alternation means better curative effect)
Time Frame
all groups: up to 4 weeks
Title
Δ[Hb]
Description
the concentration changes of deoxyhemoglobin (higher alternation means better curative effect)
Time Frame
all groups: up to 4 weeks
Secondary Outcome Measure Information:
Title
Δ[tHb]
Description
the concentration changes of blood volume (higher alternation means better curative effect)
Time Frame
all groups: up to 4 weeks
Title
NRS
Description
Numeric Rating Scale for pain (lower score means better curative effect)
Time Frame
experimental group: up to 4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients who have had non-specific low back pains at least 12 weeks now.
Healthy people who are interested in dry cupping therapy
Exclusion Criteria:
Patients who have had non-specific low back pains at least 12 weeks now.
Healthy people who are interested in dry cupping therapy
Exclusion Criteria:
Patients who have low back pain due to specific and known etiological causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome, cauda equinal syndrome).
Patients who are inappropriate to the wet cupping treatment.
AIDS, Active Hepatitis, Tuberculosis, Syphilis
Patients who regularly take anticoagulants, antiplatelet drugs
Anemia, thrombocytopenia
Hemorrhagic disease like hemophilia
Diabetes
Severe cardiovascular disease
Kidney diseases (renal failure, chronic renal disease)
Patients who have experiences of wet cupping treatment during last 3 months.
Patients who have had treatment for low back pain during last 2 weeks.
Patients who are in pregnancy or have plan to conception.
Patients who have vertebra surgery or have plan of surgery.
Patients who are inappropriate to join this trial judged by the radiologists or specialists.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ting Li
Phone
18002127296
Email
t.li619@foxmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Chenyang Gao
Phone
16622803399
Email
gaocy@bme.cams.cn
12. IPD Sharing Statement
Plan to Share IPD
No
Links:
URL
https://www.osapublishing.org/boe/abstract.cfm?uri=boe-8-1-223
Description
Significant and sustaining elevation of blood oxygen induced by Chinese cupping therapy as assessed by near-infrared spectroscopy
Learn more about this trial
Hemodynamic Changes During Dry Cupping Therapy on Low Back Pain
We'll reach out to this number within 24 hrs